ACP
GWPH

Acuta Capital Partners’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Acuta Capital Partners’s Portfolio GWPH Stock Details GWPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-40,000
Closed -$4.47M – 80
2016
Q4 		$4.47M Sell
40,000
-1,487
-4% -$179K 1.66% 19
2016
Q3 		$5.51M Buy
+41,487
New +$3.97M 2.07% 17

Other funds holding GWPH

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Acuta Capital Partners's GWPH Position: Q1 2017 in Review

Acuta Capital Partners sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q1 2017, closing a stake of 40,000 shares — an estimated $4.47M sold.

Acuta Capital Partners first reported a position in GWPH in Q3 2016 and held it in 2 quarters. The position peaked at $5.51M in Q3 2016. 179 funds tracked by Wall St. Rank hold GWPH as of Q1 2017.

  • Acuta Capital Partners reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q1 2017 after selling out during the quarter.
  • Acuta Capital Partners sold 40,000 GW Pharmaceuticals Plc American Depositary Shares shares in Q1 2017, an estimated $4.47M.
  • Acuta Capital Partners first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q3 2016 and held it in 2 quarters.
  • Acuta Capital Partners's GW Pharmaceuticals Plc American Depositary Shares position peaked at $5.51M in Q3 2016.
  • 179 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q1 2017.

Based on Acuta Capital Partners's 13F filing for Q1 2017, filed 15 May 2017.